Today's Low | Today's High | |
---|---|---|
1,618.65 1,617.35 |
| 1,685.00 1684.90 |
52 Week Low | 52 Week High | |
---|---|---|
556.85 (07-Dec-2023) 556.60 (07-Dec-2023) |
| 1,685.00 (29-Nov-2024) 1,684.90 (29-Nov-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
30 | 0 |
Bid Price | Quantity |
---|---|
1,676.45 | 30.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 30 |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | ₹85.21 Cr |
PE Ratio (TTM): | 69.62 |
PB Ratio: | 6.77 |
Industry P/E: | 69.87 |
Debt to Equity: | - |
ROE: | 9.72 |
EPS (TTM): | 23.36 |
Book Value: | 227.38 |
Face Value: | 10.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 198.76 Cr | 182.92 Cr | 209.90 Cr | 159.76 Cr | 165.25 Cr |
Profit | 20.24 Cr | 10.78 Cr | 64.87 Cr | 6.73 Cr | -3.32 Cr |
Expense | 186.70 Cr | 174.03 Cr | 184.91 Cr | 161.96 Cr | 174.41 Cr |
Comprehensive income | 19.01 Cr | 10.72 Cr | 65.79 Cr | 6.36 Cr | -3.69 Cr |
EPS | 4.40 | 5.28 | 15.89 | 1.65 | -0.81 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Orchid Pharma Limited | Nov, 2020 Dec, 1993 | Pharmaceuticals Pharmaceuticals | ORCHPHARMA ORCHPHARMA |
Promoters | |
---|---|
72.40% |
Public | |
---|---|
27.60% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
72.40% |
Public | |
---|---|
27.60% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
72.40% |
Public | |
---|---|
27.60% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
89.96% |
Public | |
---|---|
10.04% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
89.96% |
Public | |
---|---|
10.04% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 1,618.65 on the NSE (National Stock Exchange) to a maximum of 1,685.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,617.35 to a high of 1,684.90.
The stock's performance over the past 52 weeks reveals a low of 556.85 (occurred on 07-Dec-2023) and a high of 1,685.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 556.60 (on 07-Dec-2023), and the 52-week high is 1,684.90 (on 29-Nov-2024).
The stock's performance over the past 52 weeks reveals a low of 556.85 (occurred on 07-Dec-2023) and a high of 1,685.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 556.60 (on 07-Dec-2023), and the 52-week high is 1,684.90 (on 29-Nov-2024).
The total volume is 1, and the total traded value is 20.93 (₹ Lakhs).
The upper circuit limit is 1,948.60, and the lower circuit limit is 1,299.10.
The market cap is ₹85.21 Cr, and the PE ratio (TTM) is 69.87.
The PB ratio is 7.39, industry P/E is 69.87 .
ROE is 9.72, EPS is 23.36, book value is 227.38
In Sep 2023, Revenue is ₹1987553000.00, and Profit is ₹202417000.00. In Jun 2023, Revenue is ₹1829198000.00, and Profit is ₹107751000.00.
The company, Orchid Pharma Limited, was listed in Nov 2020 and belongs to the Pharmaceuticals industry. Its NSE symbol is ORCHPHARMA.
As of latest available update, promoters hold 72.40%, the public holds 27.60%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.